OneStep
OneStep turns smartphones into clinical-grade motion tools, helping patients and healthcare professionals measure gait, balance, and mobility to identify risk, track recovery, and personalize care.
Problem & solution
Healthcare organizations lack scalable, objective data on how patients move and function in daily life. OneStep turns any smartphone into a clinical-grade motion analysis platform, using passive monitoring and guided assessments to measure gait, balance, and mobility. Providers, health systems, medical device companies, and life sciences organizations use these insights to detect risk, track recovery, evaluate treatments, and improve outcomes.
Primary customers & users
Customers include health systems, rehabilitation and senior-care providers, home-health organizations, medical-device companies, and life-sciences companies. Buyers are clinical, operations and research leaders. Users include clinicians, care teams, researchers, and patients.
Differentiation
Unlike wearables, cameras, or lab-based gait systems, OneStep requires only the patient’s smartphone. It combines passive, real-world monitoring with guided clinical assessments to deliver validated mobility insights at scale—without dedicated hardware, clinic visits, or changes to existing workflows.
Current traction
OneStep serves 75+ enterprise customers across 500+ senior-living communities and 15+ health systems, supporting mobility care for over 250,000 patients annually. Customers and partners include Mayo Clinic, Zimmer Biomet, BAYADA, and the U.S. Department of Veterans Affairs. Deployments have demonstrated 23–25% fewer falls and up to 42% faster recovery. OneStep is in the $10m-$50m ARR range and is FDA-listed, HIPAA-compliant, and ISO 13485 and ISO 27001 certified.
How Summit participants can help
We welcome introductions to senior leaders at health systems, payers, risk-bearing organizations, senior-care and home-health providers, and medical-device or life-sciences companies. We are particularly interested in partners seeking scalable mobility monitoring, clinical-development collaborations, and strategic opportunities to expand globally.